HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lei Shi Selected Research

bisperoxo(1,10- phenanthroline)oxovanadate(1- )

7/2013Inhibition of protein tyrosine phosphatases in spinal dorsal horn attenuated inflammatory pain by repressing Src signaling.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Lei Shi Research Topics

Disease

283Neoplasms (Cancer)
11/2022 - 06/2008
58Infections
06/2022 - 01/2004
56Inflammation (Inflammations)
08/2022 - 03/2005
45Neoplasm Metastasis (Metastasis)
06/2021 - 08/2009
43Glioma (Gliomas)
05/2022 - 10/2008
43Carcinogenesis
01/2022 - 06/2008
42Breast Neoplasms (Breast Cancer)
11/2022 - 06/2008
27Wounds and Injuries (Trauma)
09/2022 - 08/2005
25Pain (Aches)
03/2022 - 05/2007
24Glioblastoma (Glioblastoma Multiforme)
01/2021 - 09/2010
21Nasopharyngeal Carcinoma
10/2021 - 06/2008
19Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
09/2022 - 08/2009
18Hepatocellular Carcinoma (Hepatoma)
06/2022 - 11/2011
18COVID-19
01/2022 - 01/2020
18Colorectal Neoplasms (Colorectal Cancer)
01/2020 - 01/2011
17Fibrosis (Cirrhosis)
01/2022 - 07/2010
17Cardiovascular Diseases (Cardiovascular Disease)
10/2021 - 11/2004
17Lung Neoplasms (Lung Cancer)
01/2021 - 08/2009
16Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2022 - 01/2013
15Hypoxia (Hypoxemia)
02/2022 - 05/2011
13Stroke (Strokes)
06/2022 - 10/2012
13Hypertension (High Blood Pressure)
07/2021 - 05/2007
12Atherosclerosis
05/2022 - 09/2010
12Colonic Neoplasms (Colon Cancer)
01/2022 - 04/2013
11Body Weight (Weight, Body)
12/2022 - 01/2013
11Virus Diseases (Viral Diseases)
01/2022 - 06/2004
11Leukemia
11/2021 - 02/2010
11Hypersensitivity (Allergy)
01/2021 - 05/2011
10Pneumonia (Pneumonitis)
09/2022 - 12/2017
10Melanoma (Melanoma, Malignant)
06/2022 - 04/2012
10Hemorrhage
01/2022 - 05/2011
10Prostatic Neoplasms (Prostate Cancer)
01/2022 - 10/2006
10Stomach Neoplasms (Stomach Cancer)
01/2022 - 11/2011
10Urinary Bladder Neoplasms (Bladder Cancer)
07/2020 - 01/2007
9Disease Progression
11/2022 - 11/2008
9Starvation
11/2022 - 10/2010
9Non-alcoholic Fatty Liver Disease
01/2022 - 08/2013
9Carcinoma (Carcinomatosis)
01/2022 - 04/2008
9Lymphatic Metastasis
03/2017 - 04/2008
8Type 2 Diabetes Mellitus (MODY)
06/2022 - 05/2011
8Reperfusion Injury
05/2022 - 07/2005
8Sepsis (Septicemia)
04/2022 - 08/2017
8Hepatitis B
01/2022 - 01/2015
8Adenocarcinoma
01/2022 - 04/2008
8Adenocarcinoma of Lung
11/2021 - 03/2019
8Ischemia
01/2021 - 08/2006
7Obesity
12/2022 - 09/2008
7Colitis
09/2022 - 06/2015

Drug/Important Bio-Agent (IBA)

113Proteins (Proteins, Gene)FDA Link
07/2022 - 11/2004
50Pharmaceutical PreparationsIBA
01/2022 - 01/2005
48MicroRNAs (MicroRNA)IBA
11/2022 - 10/2008
39Biomarkers (Surrogate Marker)IBA
05/2022 - 02/2009
361-phenyl-3,3-dimethyltriazene (PDT)IBA
09/2022 - 07/2015
30Messenger RNA (mRNA)IBA
11/2022 - 08/2006
30Biological ProductsIBA
01/2022 - 02/2006
29AcidsIBA
09/2022 - 03/2009
27Long Noncoding RNAIBA
12/2021 - 01/2014
25CytokinesIBA
01/2022 - 01/2007
20DNA (Deoxyribonucleic Acid)IBA
01/2022 - 11/2006
19EnzymesIBA
06/2022 - 04/2008
18VaccinesIBA
03/2022 - 11/2010
17Interleukin-6 (Interleukin 6)IBA
07/2022 - 01/2011
16RNA (Ribonucleic Acid)IBA
04/2022 - 04/2013
15InterleukinsIBA
01/2022 - 06/2013
14Therapeutic UsesIBA
07/2022 - 08/2013
14AntigensIBA
01/2022 - 04/2008
14Phosphotransferases (Kinase)IBA
01/2022 - 01/2013
14CollagenIBA
01/2021 - 05/2002
14Small Interfering RNA (siRNA)IBA
07/2019 - 12/2007
13LipidsIBA
12/2022 - 12/2007
13CateninsIBA
07/2022 - 06/2013
13Glucose (Dextrose)FDA LinkGeneric
06/2022 - 06/2008
12Interleukin-10 (Interleukin 10)IBA
07/2022 - 01/2011
12Peptides (Polypeptides)IBA
01/2022 - 05/2008
12LigandsIBA
01/2022 - 08/2009
12Temozolomide (Temodar)FDA LinkGeneric
10/2016 - 09/2010
11AntioxidantsIBA
12/2022 - 11/2015
11Transcription Factors (Transcription Factor)IBA
01/2022 - 12/2007
11Reactive Oxygen Species (Oxygen Radicals)IBA
01/2021 - 11/2012
10AntibodiesIBA
01/2021 - 05/2012
10C-Reactive ProteinIBA
01/2021 - 04/2012
9Immune Checkpoint InhibitorsIBA
09/2022 - 11/2018
9Anti-Bacterial Agents (Antibiotics)IBA
01/2022 - 06/2015
9Transforming Growth Factors (Transforming Growth Factor)IBA
01/2022 - 07/2010
8ErbB Receptors (EGF Receptor)IBA
11/2022 - 12/2013
8Analgesics (Analgesic Drugs)IBA
01/2022 - 02/2008
8Indicators and Reagents (Reagents)IBA
01/2022 - 02/2016
8Matrix Metalloproteinases (MMPs)IBA
08/2021 - 07/2010
8demethoxycurcuminIBA
11/2020 - 09/2015
8Complement System Proteins (Complement)IBA
01/2020 - 07/2005
8Adenosine Triphosphate (ATP)IBA
01/2019 - 02/2007
8Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
07/2018 - 08/2006

Therapy/Procedure

128Therapeutics
10/2022 - 01/2007
36Drug Therapy (Chemotherapy)
09/2022 - 02/2010
34Photochemotherapy (Photodynamic Therapy)
09/2022 - 01/2013
22Immunotherapy
01/2022 - 05/2011
15Radiotherapy
01/2022 - 06/2008
14Lasers (Laser)
01/2022 - 05/2007
9Debridement
05/2021 - 11/2009
8Aftercare (After-Treatment)
02/2020 - 09/2012